주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-26 16:52 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
Bio
목록
(
총 :
413 )
기사목록 보기 형태
제목형
요약형
포토형
Brain Asset Management selected as preferred bidder for SK pharmteco’s pre-IPO series
Lee Han-soo
2023.07.18 13:26
Bioventures defy slowdown, launch IPOs in Korea in second half
Lee Han-soo
2023.07.14 16:12
Daewoong Bio to invest $39 mil. to build new cephalosporin antibiotics plant
Lee Han-soo
2023.07.14 11:21
Celltrion’s share buybacks fuel speculation of merger between affiliates
Lee Han-soo
2023.07.13 15:55
Samsung Bioepis, Organon's Humira biosimilar added to Cigna's list of preferred drugs
Lee Han-soo
2023.07.12 16:46
Bioplus-Interphex 2023: Experts highlight importance of startup-pharma collabo
Marianne Chang
2023.07.12 15:42
Samsung Biologics, 1st Korean firm to win ₩2 trillion in annual CMO orders
Lee Han-soo
2023.07.10 15:32
NCC, Korea University license out prognostic breast cancer biomarker to CbsBiosciences
Marianne Chang
2023.07.06 10:43
Samsung Bioepis, Celltrion Healthcare launch Humira biosimilar in US
Lee Han-soo
2023.07.03 13:30
‘Asthma care in Korea reminds me of Canada 8 years ago’
Kim Yun-mi
2023.07.03 11:48
IBS develops brain mapping to predict tendency to focus on negative thoughts, level of depression
Marianne Chang
2023.06.30 15:51
Celltrion seeks U.S. marketing authorization for Eylea biosimilar
Lee Han-soo
2023.06.30 10:51
처음
이전
이전
이전
21
22
23
24
25
26
27
28
29
30
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기